MN

Murugeswaran Nandhini

Active Director Director DIN 09475730
DIN 09475730 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Murugeswaran Nandhini

Data last updated:

Murugeswaran Nandhini is a Director at Ever Heed Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09475730
Primary Designation Director
Industry Chemicals
First Appointment 21 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ever Heed Pharma Private Limited U24290TG2022PTC158952
Director21 Jan 20222022Active

Board colleagues of Murugeswaran Nandhini

NameDINCompanyDesignation
Mohamed Irshad09475728Ever Heed Pharma Private LimitedDirector
Mubina09475729Ever Heed Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ever Heed Pharma Private Limited
Premium access

Shareholding and investment profile for Murugeswaran Nandhini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murugeswaran Nandhini

Murugeswaran Nandhini currently holds 1 directorship: Ever Heed Pharma Private Limited (Director, since 21 Jan 2022).

Murugeswaran Nandhini was first appointed on 21 Jan 2022 as Director at Ever Heed Pharma Private Limited.

The current boards of Murugeswaran Nandhini's companies include Mohamed Irshad (Ever Heed Pharma Private Limited), Mubina (Ever Heed Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available